Medical & Pharmaceuticals

ARCLIFFE LLP works with multinational innovative and generics pharmaceutical companies, health care providers and researchers. We give regulatory advice and we defend against patent infringement, professional liability and disciplinary charges.

We advise on industry specific M&A and finance transactions, and we counsel on licensing, development and distribution arrangements.

A selection of our collective knowledge, includes advising:

  • A Blue Chip Private Equity house in the acquisition of a distributor of pharmaceuticals products in CEE.
  • Novartis Pharma on various regulatory matters (issuance of marketing authorisations, protection of innovative medicinal products, prices of medicinal products) and administrative disputes with governmental authorities.
  • Roche in regards to protection of their innovative medicinal products as well as the implementation of clinical trials related agreements.
  • Abbott Laboratories on various regulatory matters (development of clinical trials, interactions with health care professionals, anti-bribery and interactions with governmental officials).
  • Eli Lilly on various legal matters pertaining to regulatory issues (clinical studies, observational studies, prices of medicinal products, anti-bribery and interactions with governmental officials).
  • Lundbeck and Merz Pharmaceuticals in respect to regulatory matters pertaining to the legal protection of certain innovative medicines.
  • Beaufour Ipsen Pharma on the implementation of clinical trials and epidemiological studies agreements.

Key Office Contacts

Frantisek Horvath

Profile & Contact
Jan Pechman

Profile & Contact
Iulia Berea

Profile & Contact
Catalin Vlasceanu

Profile & Contact
Boris Ivanov

Profile & Contact